pancreatic cancer and glp 1 Can GLP-1 medications really lower your risk? 🧐 Because obesity is linked to 13 types of cancer, researchers are seeing positive trends connecting weight-loss drugs to cancer prevention. James L. Wells GLP-1 receptor agonists—the class of

For patients with established atherosclerotic cardiovascular disease and overweight or obesity, the SELECT data support semaglutide 2.4 mg

the way that you eat is going to produce more or less GLP-1 more on that later

The medication works by: Enhancing insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia Suppressing glucagon release when blood glucose levels are elevated Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite regulation in the hypothalamus to decrease food intake Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on individual tolerance and therapeutic response

But health is multifactorial. Thats where sport nutrition professionals increasingly come in, helping athletes and nonathletes transform science into practical, sustainable habits

Studies on GLP-1 have demonstrated its protective effects against cardiomyocytes apoptosis due to inflammation and highlighted its potential role in alleviating previous chronic inflammation due to preexisting atherosclerotic plaques, both of which are considered as SARS-CoV-2 risk factors

Why Your Hormones Matter Your weight-health hormones do more than move the scale